Sonavex’s multidisciplinary team of surgeons, scientists, technologists and business leaders brings decades of experience in developing, commercializing, and scaling novel medical technologies
Surgical ultrasound is
To create novel and automated ultrasound technology that empowers clinicians with actionable data to deliver superior patient care and deliver savings to the healthcare system.
Commitment to Patients & Clinicians
Above all else, we work every day to help clinicians improve the lives of patients
Teamwork & Respect
Our work requires an interdisciplinary team effort and we foster strong teamwork where everyone’s opinions are heard and respected
Creativity & Innovation
We approach hard problems with creative and bold solutions
Integrity & Accountability
We have a high standard of integrity in which each team member works towards our mission and is accountable for their actions
Be the Best
We strive to be the best team, with the best solutions, to deliver superior results for patients
Sonavex’s multidisciplinary team of surgeons, scientists, technologists and business leaders brings decades of experience in developing, commercializing, and scaling novel medical technologies
Mr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
Dr. O’Brien Coon is President and Chief Medical Officer, guiding overall company development, clinical and business strategy, and R&D.
Michelle Zwernemann, MSE, is a biomedical engineer with over 10 years of experience in medical device development and commercialization
John most recently held the role of CBO for AV Medical Technologies, Ltd where he led all US operations from pre-commercialization to a successful exit to Medtronic.
Dr. Xin (Ben) Kang is Director of Research and Development, overseeing research and product development in addition to invention and exploration of new projects.
Katy Feeny is a biomedical engineer with over 10 years of experience in the medical device industry developing and executing clinical research strategies.
Mr. Buss has over 25 years of experience in the medical device industry directing quality and regulatory affairs programs for global companies, including over 20 years with GE Healthcare.
Mr. Niland joined Harpoon Medical as its president and CEO in 2014 and has since sold the company to Edwards Lifesciences for $100M upfront and up to $250M overall.
Mr. Hallenbeck has spent over 30 years working with inventors, entrepreneurs and university tech transfer offices in developing, funding, licensing and commercializing technology.
Dr. Prince is the William B. Kouwenhoven Professor of Computer Engineering, Radiology and Biomedical Engineering at Johns Hopkins University.
Mr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
Dr. O’Brien Coon is President and Chief Medical Officer, guiding overall company development, clinical and business strategy, and R&D.